Larry Ellberger, Director at Celldex Therapeutics, Inc. (CLDX), bought 5,000 shares at $4.48 ($22K) on 2009-11-30, disclosed to the SEC on 2009-11-30.
Open-market purchase of $22k CLDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.46 | 300 | $1K | 6.0% |
| 2 | $4.47 | 3,300 | $15K | 66.0% |
| 3 | $4.48 | 1,400 | $6K | 28.0% |
| Total | $4.47 avg | 5,000 | $22K | 100% |
| Filing → |
| CLDX | BUY | 2015-08-19 | $80K | — | Filing → |
| CLDX | BUY | 2015-08-14 | $83K | — | Filing → |
| CLDX | SELL | 2013-12-10 | $434K | — | Filing → |